Our International Expertise

Trinity has extensive experience supporting healthcare clients with a wide range of commercial business issues internationally.

Learn more about our expertise in your region:

Latest International Intelligence

White Papers

Cracking the Code of the Access Landscape in China

As the market becomes increasingly crowded and budget constraints continue in China, downward pricing pressure to secure National Reimbursement Drug List (NRDL) inclusion remains the top challenge for multinational pharma companies in this market. However, the significant uptake post-NRDL inclusion and broad access offer substantial opportunities for innovative products with clinical differentiation.   In this white […]

 Read More


The German Financial Stabilization of Statutory Health Insurance System Act

October 31, 2022 Executive Summary: Key Policy Updates AMNOG Rebate Negotiations AMNOG* rebate negotiations will be modified to give the GKV-SV increased powers in the pricing negotiations. HIGH P&MA IMPACT: The new negotiation framework increases the threshold of added benefit required for therapies to receive a premium vs. comparator therapies, specifically by limiting the pricing […]

 Read More


Brazil’s Latest Updates to Drug Coverage in the Private Sector: Anticipated Impact and Implications

October 14, 2022 Executive Summary Introduction Agência Nacional de Saúde Suplementar (ANS) is the Brazilian regulatory agency linked to the Ministry of Health that oversees the private healthcare sector and insurance companies within the country. Key responsibilities of ANS include defining the legislation to regulate private plans and defining the minimum coverage that plans must […]

 Read More

If you have any questions, we’re here to answer them.
We look forward to helping identify solutions for you.